Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025)

Cresco Labs' (CRLBF) quarterly Cash from Investing Activities came in at -$13.2 million in Q4 2025, down 339.5% YoY from $5.5 million in Q4 2024, and down 116.23% on a QoQ basis from -$6.1 million in Q3 2025.

Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Cresco Labs (CRLBF) has 7 years of Cash from Investing Activities data on file, last reported at -$13.2 million in Q4 2025.

  • Quarterly Cash from Investing Activities fell 339.5% year-over-year to -$13.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$28.6 million (down 49.61% YoY) and the FY2025 annual result came in at -$40.7 million, down 61.34% from the prior year.
  • Cash from Investing Activities fell to -$13.2 million in Q4 2025, from -$6.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $23.5 million in Q3 2022 to a low of -$64.1 million in Q4 2021.
  • A 5-year average of -$15.2 million and a median of -$12.5 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 581.77% — and 2022, when it jumped 168.04%.
  • Tracing CRLBF's Cash from Investing Activities over 5 years: stood at -$64.1 million in 2021, then surged by 80.57% to -$12.5 million in 2022, then surged by 120.95% to $2.6 million in 2023, then sank by 215.48% to -$3.0 million in 2024, then sank by 339.5% to -$13.2 million in 2025.
  • The last three Cash from Investing Activities figures came in at -$13.2 million (Q4 2025), -$6.1 million (Q3 2025), and -$3.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Cresco Labs 292.94 Mn 228.83 Mn 86.95 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -13.24 Mn
Dec 31, 2025 -13.24 Mn
Sep 30, 2025 -6.12 Mn
Sep 30, 2025 -6.12 Mn
Dec 31, 2024 -3.01 Mn
Dec 31, 2024 -3.01 Mn
Sep 30, 2024 -6.27 Mn
Sep 30, 2024 -6.27 Mn
Dec 31, 2023 2.61 Mn
Dec 31, 2023 2.61 Mn
Sep 30, 2023 -12.48 Mn
Sep 30, 2023 -12.48 Mn
Dec 31, 2022 -12.45 Mn
Dec 31, 2022 -12.45 Mn
Sep 30, 2022 23.48 Mn
Sep 30, 2022 23.48 Mn
Dec 31, 2021 -64.11 Mn
Dec 31, 2021 -64.11 Mn
Sep 30, 2021 -34.52 Mn
Sep 30, 2021 -34.52 Mn